- Report
- September 2025
- 86 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- May 2025
- 165 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- February 2026
- 160 Pages
Global
From €2931EUR$3,320USD£2,526GBP
€3663EUR$4,150USD£3,158GBP
- Report
- February 2026
- 160 Pages
Global
From €2931EUR$3,320USD£2,526GBP
€3663EUR$4,150USD£3,158GBP
- Report
- February 2026
- 160 Pages
Global
From €2931EUR$3,320USD£2,526GBP
€3663EUR$4,150USD£3,158GBP
- Report
- February 2026
- 101 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- November 2025
- 88 Pages
Global
From €3500EUR$4,248USD£3,123GBP
- Report
- November 2025
- 210 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- October 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- October 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- January 2026
- 270 Pages
Global
From €3189EUR$3,613USD£2,749GBP
€3751EUR$4,250USD£3,234GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 210 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- November 2025
- 150 Pages
Global
From €4281EUR$4,850USD£3,690GBP
- Report
- October 2025
- 210 Pages
Global
From €4281EUR$4,850USD£3,690GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more